Eignapharma announces that it has reached a collaboration agreement with Biogem (Molecular Biology and Genetics Institute). Biogem is specialised in lab scale development and production of biosimilars, monoclonal antibodies, new biological entities and related preclinical studies, either own promoted or contract projects assigned by industry stakeholders. Under this agreement Eignapharma will use its commercial efforts to put at the industry disposal Biogem’s research and development capabilities consisting on documented small-scale processes and fully protocolised technology transfers procedures to allow a safe scaleup to industrial production.